About: Faropenem Medoxomil     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Faropenem Medoxomil
rdfs:subClassOf
Concept_In_Subset
Semantic_Type
  • Pharmacologic Substance
Preferred_Name
  • Faropenem Medoxomil
UMLS_CUI
  • C1880735
CAS_Registry
  • 141702-36-5
FDA_UNII_Code
  • 5OK523O4FU
Contributing_Source
  • FDA
Chemical_Formula
  • C17H19NO8S
Legacy_Concept_Name
  • Faropenem_Medoxomil
FULL_SYN
  • (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-(5R,6S)-6-[(R)-1-hydroxyethyl]-7-oxo-3-[(R)-2-tetrahydrofuryl]-4-thia-1-aza-bicyclo[3,2,0]hept-2-ene-carboxylate)SNNCI
  • Faropenem DaloxateSYNCI
  • Faropenem MedoxomilPTNCI
  • FAROPENEM MEDOXOMILPTFDA5OK523O4FU
DEFINITION
  • A daloxate ester prodrug form of faropenem, a penem with a tetrahydrofuran substituent at position C2, with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes. Faropenem medoxomil is hydrolyzed in vivo to release the active free acid. Compared with imipenem, faropenem has improved chemical stability and reduced central nervous system effects. In addition, faropenem is resistant to hydrolysis by many beta-lactamases.NCI
code
  • C65621
http://linked.open...y/mesh/hasConcept
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software